| |
|
Course
Description
This
course will present current controversial issues in the
diagnosis, management and treatment of renal osteodystrophy.
The target audience is nephrologists, dietitians, nurse
practitioners and physician assistants.
Learning
Objectives
At the conclusion of this
program participants should be able to:
-
Discuss
the current spectrum of renal bone diseases in patients
with renal failure and its impact on K/DOQI recommendations.
-
Review the process of
vascular calcification in renal failure.
-
Review the impact of new
phosphate binders and alternative dialysis techniques
in the control of hyperphosphatemia.
-
Review the value of new
vitamin D analogs and calcimimetic agents in the control
of secondary hyperparathyroidism.
-
Recognize the impact of
therapy with different vitamin D metabolites on long term
survival.
Enrollment
$50.00 physicians
$35.00
Dietitians/Nurses
By
Mail
Send
the completed enrollment
form to:
Office
of Continuing Medical Education
David Geffen School of Medicine at UCLA
Contemporary Issues in Renal Osteodystrophy
10920 Wilshire Blvd., Suite 1060
Los
Angeles, CA 90024-6512
fax
form to: 310-794-2624
By
Phone
to
use your MasterCard, Visa, or Discover, call (310)
794-2620
Refunds
Due
to the low enrollment fee no refunds will be granted.
A full refund will be granted if the course is canceled
or rescheduled.
Friday,
January 23, 2004 |
| 8:00 |
Registration/Continental
Breakfast |
| Morning |
|
| Session
I |
Renal
Bone Disease |
| 8:30 |
Overview
of Renal Bone Disease and Its Treatment |
| 9:15 |
Diagnostic
Problems in Renal Osteodystrophy
Update of PTH Assays—What Gets Measured and
It Is
Worthwhile?
Bone Biopsy for Everyone?
William G. Goodman, MD |
| 10:00 |
Break |
| Session
II |
Mineral
Metabolism |
| 10:30 |
Vitamin
D Nutrition in Chronic Kidney Disease—Too Much
or Not Enough
Calcitriol and Vitamin D Analogs—The Right Stuff?
Assessing Vitamin D Nutrition
Kevin J. Martin, M.B. B.C.h., F.A.C.P. |
| 11:15 |
Evolving
Concepts in Vascular Calcification—Beyond Passive
The Types of Arterial Calcification in Chronic Kidney
Disease
Vascular Calcification as a Regulated Process
Sharon Moe, MD |
| 12:00 |
Lunch |
| Afternoon |
|
| Session
III |
Managing
Mineral Metabolism and Renal Bone Disease |
| 1:30 |
Changing
Concepts in Managing Phosphorus Retention—Is
There Life After Calcium
New Phosphate-binding Agents
Alternative Dialysis Strategies
Geoffrey A. Block, MD |
| 2:15 |
Vitamin
D Sterols and Calcimimetic Agents—What's New
and How Do They Work?
New Therapeutic Strategies
Insights about Monitoring Treatment and K/DOQI
Dennis L. Andress, MD |
| 3:00 |
Break |
| Session
IV |
Measuring
Therapeutic Outcomes |
| 3:30 |
Vitamin
D Analogs and Patients Survival During Long-Term Dialysis—The
Pros and Cons
Potential Mechanisms
Ravi Thadhani, MD, MPH |
| 4:15 |
Open
Discussion
Case Presentations |
| 5:00 |
Adjourn/Reception |
Course
Chair
William
G. Goodman, MD
Professor
of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA
Isidro B. Salusky, MD
Professor of Pediatrics
David Geffen School of Medicine at UCLA
Los Angeles, CA
Faculty
Dennis
Andress, MD
Professor of Medicine/Division of Nephrology
Section Head, Nephrology VA-PSHCS
Seattle, WA
Geoffrey A. Block, MD
Director of Clinical Research
Denver Nephrologists
Denver, CO
Kevin J. Martin, M.B. B.C.h., F.A.C.P.
Professor of Internal Medicine
Director of the Division of Nephrology
St. Louis University
St. Louis, MO
Sharon Moe, MD
Associate Professor of Medicine
Indiana University School of Medicine
Indianapolis, IN
Ravi Thadhani, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Massachusetts General Hospital
Boston, MA
CME
Sponsor
The
Office of Continuing Medical Education, David Geffen School
of Medicine at UCLA, is accredited by the Accreditation
Council for Continuing Medical Education to sponsor continuing
medical education for physicians.
Accreditation
and Approval
The
Office of Continuing Medical Education, David Geffen
School of Medicine at UCLA, designates this educational
activity for up to 7 Category 1 credits towards the
AMA Physician’s Recognition Award.
Each physician should claim only those credits that
he/she actually spent in the educational activity.
Continuing education credit from the Commissions on
Dietetic Registration has been applied for.
Disclosure
The
FDA has issued a concept paper that classifies the commercial
support of scientific and educational programs as promotional
unless it can be affirmed that the program is truly independent
and free of commercial influence. Along with independence,
the FDA requires that non-promotional, commercially supported
education be objective, balanced, and scientifically rigorous.
The policy further states that all potential conflicts
of interest of the continuing medical education staff
and faculty be fully disclosed to the program’s
participants. We at UCLA fully endorse the letter and
spirit of this concept. In compliance with this policy,
we will disclose to the program audience any potential
conflict(s) of interest related to the presentations made
by faculty participating in sponsored or jointly sponsored
programs by the David Geffen School of Medicine at UCLA.
Meeting
Location
Hotel
Casa Del Mar
1910 Ocean Way
Santa Monica, CA 90405
(310) 581-5533
A
limited number of rooms have been reserved at the group
rate of $305 (rate based upon availability), plus tax.
Contact hotel directly.
Daytime
parking at Hotel Casa Del Mar is $10.
|
| |
|
|
